{"data":{"id":"us-ct/conn.-gen.-stat.-38a-483c","jurisdiction":"us-ct","citation":"Conn. Gen. Stat. § 38a-483c","heading":"Coverage and notice re experimental treatments. Appeals.","body":"(a) Each individual health insurance policy delivered, issued for delivery, renewed, amended or continued in this state shall define the extent to which it provides coverage for experimental treatments.\n(b) No such health insurance policy may deny a procedure, treatment or the use of any drug as experimental if such procedure, treatment or drug, for the illness or condition being treated, or for the diagnosis for which it is being prescribed, has successfully completed a phase III clinical trial of the federal Food and Drug Administration.\n(c) Any person who has been diagnosed with a condition that creates a life expectancy in that person of less than two years and who has been denied an otherwise covered procedure, treatment or drug on the grounds that it is experimental may request an expedited appeal as provided in section 38a-591e and may appeal a denial thereof to the Insurance Commissioner in accordance with the procedures established in section 38a-591g.","path":["TITLE 38a. INSURANCE","CHAPTER 700c. HEALTH INSURANCE","PART II. INDIVIDUAL HEALTH INSURANCE"],"source_url":"https://www.cga.ct.gov/current/pub/chap_700c.htm#sec_38a-483c","current_through":"Revised to January 1, 2026 (2026 Supplement to the General Statutes of Connecticut, applied over the base revision of January 1, 2025)","vintage":"","retrieved_at":"2026-09-06T19:07:12Z","sha256":"b16dd550331c39b6bad4e852a7770c16cf19045de0110b76b6ed8bdb82942c9e","source_id":"us-ct","stale":false,"prev":"us-ct/conn.-gen.-stat.-38a-483b","next":"us-ct/conn.-gen.-stat.-38a-484"},"notice":"GroundRules: Original legal text. Not legal advice."}